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patients with high-risk extremity soft tissue sarcoma. A two-
tier registration was used to align the tumor VOI within each 
dynamic frame at TP1 and align the volumes at TP2 to the 
volumes at TP1. After registration, the voxel-wise transfer 
constant Ktrans within a VOI covering the whole tumor 
normalized to a reference region of normal tissue area closed 
to the tumor was calculated. The responder threshold was 
determined by linear regression via evaluating the 95% 
confidence interval [-T, T] in the residuals from the 
reference region. The difference of the voxel-wise ΔKtrans 
within the tumor between TP1 and TP2 was calculated. Three 
classes of voxels within the tumor VOI were determined: 
voxels having ΔKtrans value exceed threshold T were 
designated in red, below -T were designated in blue, and 
otherwise designated in green indicating no significant 
change. The volume fractions with respect to three sub-
volumes of the tumor VOI were computed as F+ (red voxels), 
F-(blue voxels) and F0 (green voxels). 
 
Results: The histopathology at the time of surgery confirmed 
that 3 patients were optimal responders to preoperative 
treatment (≥95% pathologic tumor necrosis percentage) and 9 
patients were sub-optimal responders (<95% necrosis 
percentage).F0, ΔKtrans and F- had significantly positive, 
positive and negative correlations with necrosis percentage 
(p < 0.05), respectively. The change of tumor size had no 
correlation with necrosis percentage. 
 
 
 
 
 
Conclusion: The results suggest that F0 and F-are more 
sensitive to early therapy response compared, which could 
provide the early prediction of treatment outcome while 
retain spatial localization of heterogeneous response to 
treatment in sarcoma. 
 
EP-1851  
Quantitative assessment of glucose metabolic rate within 
NSCLC histologies using dynamic 18F-FDG PET 
T. Meijer
1Radboud University Medical Center, Radiation Oncology, 
Nijmegen, The Netherlands 
1, D. Vriens2, M. Looijen-Salamon3, E. Visser4, L.F. 
De Geus-Oei2, J. Bussink1 
2Leiden University Medical Center, Nuclear Medicine, Leiden, 
The Netherlands 
3Radboud University Medical Center, Pathology, Nijmegen, 
The Netherlands 
4Radboud University Medical Center, Nuclear Medicine, 
Nijmegen, The Netherlands 
Purpose or Objective: Biological behavior differs between 
histologies of non-small cell lung cancer (NSCLC). Tumour 
biology and glucose metabolism influence radiosensitivity. 
The first goal of this study is to calculate glucose metabolic 
rate constants k1 (glucose transporter (GLUT) influx), k2 
(GLUT efflux), k3 (hexokinase phosphorylation) and blood 
volume (VB) in adeno- versus squamous cell NSCLC using 
dynamic 18FDG PET. Heterogeneity of these parameters will 
be assessed within different tumour regions. This will 
improve understanding tumour biology and potentially form 
the basis for dose modifications in radiotherapy.  
Besides 18FDG PET as a tool indicating radioresistant tumour 
areas, PET may be used for tumour delineation in 
radiotherapy planning. Manual tumor delineation of stage III 
NSCLC for radiotherapy planning takes a lot of effort. The 
second objective of this study is to correlate tumour 
dimensions obtained by thresholds of standardized uptake 
value (SUV; static PET), metabolic rate of glucose (MRglu; 
dynamic PET) with pathological data. The most appropriate 
method may quicken tumour delineation for radiotherapy 
planning. 
 
Material and Methods: Patients with curatively resected 
NSCLC were included in this prospective study (n=35). 
Dynamic 18FDG-PET scans were acquired during 60 minutes. 
Patlak analyses using the data acquired between 15-60 
minutes post-injection were performed to calculate 
parametric images of MRglu. The last time frame was used as 
static PET scan. Tumour volumes were delineated using 50% 
of maximum, 40% of maximum above background and FLAB 
algorithm. Maximum SUV (SUVmax) and maximum MRglu 
(MRglu;max) were calculated. In on-going analysis, volumes 
acquired by the segmentation methods are correlated with 
pathology volumes to determine the optimal delineation 
method for NSCLC. Within the most appropriate method, 
pharmacokinetic rate constants k1, k2, k3, VB are currently 
being calculated using an irreversible two-compartment 
model.  
 
Results: Initial results showed that SUVmax was higher in 
squamous cell NSCLCs versus adenocarcinomas (median 17.8 
(9-33) versus 11.6 (6-32) respectively, p=0.002). Also the 
MRglu;max was higher in squamous cell carcinomas (median 
462.6 nanomol/min/g (266.4-1366.2) versus 301.5 (129.7-
1096.5) respectively, p=0.004).  
Static volumes were larger compared to the dynamic volumes 
(p<0.001). Applying FLAB algorithm on static PET resulted in 
the largest volumes (p<0.001).  
 
Conclusion: These preliminary data support differences in 
glucose metabolism between adeno- and squamous cell 
NSCLC. In the ongoing analyses, metabolic rates of glucose 
will be studied in more detail and will be correlated to 
survival. Furthermore, tumour volumes acquired by several 
segmentation methods will be correlated with pathology 
volumes to determine the optimal delineation method. This 
optimal segmentation method may aid in radiotherapy 
delineation. 
 
EP-1852  
Predictive role of FDG-PET/CT image-derived parameters 
in locally advanced oropharyngeal cancer 
S. Broggi
1IRCCS San Raffaele Scientific Institute, Medical Physics, 
Milano, Italy 
1, I. Dell'Oca2, C. Fiorino1, E. Incerti3, M. Picchio3, 
M.L. Belli4, P. Mapelli3, A. Chiara2, N. Di Muzio2, G.M. 
Cattaneo1, R. Calandrino1 
2IRCCS San Raffaele Scientific Institute, Radiotherapy, 
Milano, Italy 
3IRCCS San Raffaele Scientific Institute, Nuclear Medicine, 
Milano, Italy 
4University of Milan, Medical Physics Specialization School, 
Milan, Italy 
 
Purpose or Objective: To investigate the predictive role of 
FDG-PET/CT image-derived parameters in patients with 
locally advanced oropharyngeal cancer undergoing IMRT, by 
S872                                                                                                                                                  ESTRO 35 2016 
_____________________________________________________________________________________________________ 
means of helical tomotherapy (HTT), with a simultaneous 
integrated boost (SIB) on FDG-positive volumes (BTV). 
 
Material and Methods: 41 patients (median age: 60; range: 
41-81) treated between November 2005 and April 2014 at our 
Institution for advanced squamocellular oropharyngeal 
disease were analyzed. Most of the patients (95%) were of 
stage III-IV; 38 patients had positive lymph nodes (N, 32 with 
more than one N). HTT was delivered with a SIB approach in 
30 fractions at different dose levels, concomitantly: 69 Gy 
(2.3 Gy/day) to FDG-positive volumes ( primary tumor (T) and 
N ), 66 Gy (2.2 Gy/day) to the tumor volume and enlarged 
nodes and 54 Gy (1.8 Gy/day) to the subclinical and elective 
treated nodes. PET metabolic parameters of FDG-positive 
volumes (T, N and T+N), including maximum and mean 
standardized uptake value (SUVmax and SUVmean), 
metabolic tumor volume (MTV) estimated at different 
thresholds 40-50-60% (MTV-40, MTV-50, MTV-60) and total 
lesion glycolysis (TLG-40, TLG-50, TLG-60) were considered. 
BTV volumes for T (BTV-T), N (BTV-N) and T+N (BTV-T+N) 
were also considered. Log rank univariate and Cox regression 
multivariate analysis were used to evaluate prognostic values 
of PET derived parameters and cancer specific overall 
survival (CSOS), local recurrence-free survival (LRFS) and 
loco-regional recurrence –free survival (LNRFS). The best cut-
off values of PET derived parameters discriminating between 
patients with/without death/relapse were assessed by ROC 
analysis. 
 
Results: The median follow-up was 37 months (range: 3-125 
months). The 3-year CSOS, LRFS and LNRFS were 88.5%, 85% 
and 80%, respectively. At univariate analysis MTV-T-60>4.4cc 
was found the most significant PET parameter correlated to 
CSOS (HR: 0.09, p=0.0078), LRFS (HR: 0.07, p=0.0017) and 
LNRFS (HR: 0.16, p=0.01). TLG-T-60, SUVmean(T+N), MTV-
T+N-60 were also found to be correlated with CSOS and LRFS. 
At multivariate analysis BTV-T+N>30.9cc and MTV-T-60>4.4cc 
were found the variables most significantly correlated with 
CSOS (AUC: 0.885; 95%CL: 0.739-0.965). MTV-T-60>4.4cc 
confirms its independent predictive role for LRFS (AUC: 
0.807; 95%CL: 0.647-0.917) and for LNRFS (AUC: 0.744; 
95%CL: 0.577-0.872). 
 
 
Conclusion: FDG PET/CT performed as guide for HTT SIB 
treatment in patients affected by advanced oropharyngeal 
cancer is predictive of patient’s outcome. MTV-T-60 was 
found the best predictor for CSOS, LRFS and LRNFS. FDG-
PET/CT image-derived parameters might be useful to select 
more personalized treatment strategies. 
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Purpose or Objective: Both the standardized uptake value 
(SUV), acquired by 18F-flurodeaxyglucose positron emission 
tomography/computed tomography (18F-FDG PET/CT), and 
the apparent diffusion coefficient (ADC) acquired by 
diffusion-weighted magnetic resonance imaging (DW-MR) are 
well established measures for treatment response assessment 
in neoadjuvant esophageal cancer treatment. However, these 
functional imaging parameters may refer to different aspects 
of tumor pathophysiology. Currently it is unclear whether 
these two prognostic biomarkers provide similar information 
or represent independent biomarkers. Therefore the aim of 
this study was to evaluate the correlation between SUV and 
ADC measurements in untreated esophageal tumors. 
 
Material and Methods: This prospective study included 33 
patients with histologically proven esophageal cancer who 
underwent 18F-FDG PET/CT and DW-MR examinations within 
3 weeks before therapy. Tumor glucose metabolism was 
evaluated by the maximum and mean SUV (SUVmax and 
SUVmean) on the 18F-FDG PET/CT images. Minimum and 
mean ADC values (ADCmin and ADCmean, calculated with b 
values of 0,200 and 800 s/mm2) were measured in the same 
lesions. Lesions with a diameter larger than 3 cm were 
matched and a voxelwise analysis of ADC and SUV was 
performed. Spearman’s rank correlation coefficients were 
used to assess the correlation between 18F-FDG PET and ADC 
metrics. Also the tumor ADCmean and SUVmax was compared 
between squamous cell carcinomas and adenocarcinomas, 
and between moderately and poorly differentiated tumors. 
 
Results: Mean ADCmean and ADCmin of the 33 included 
esophageal cancer tumors were 1.8 ± 0.4 and 0.8 ± 0.4, *10-
3mm2/s, respectively. Mean SUVmean and Mean SUVmax 
were 8.3 ± 4.2 and 17.4 ± 9.6, respectively. The SUV and ADC 
values as measures of glucose metabolism and cell density, 
respectively, showed weak to very weak non-significant 
correlations only (ADCmin vs SUVmax; r=0.30, p=0.09], 
[ADCmin vs. SUVmean r=0.30 p=0.09], [ADCmean vs SUVmax 
r=0.17 p=0.36], [ADCmean vs SUVmean r=0.14 p=0.43]) 
(Figure 1). The voxel-wise analysis of 16 esophageal tumors 
with diameters larger than 3 cm showed a weak but 
significant negative correlation between ADC and SUV in 11 
patients. ADCmean was significantly related to histological 
tumor grade (2.0 ± 0.3 in moderately differentiated tumors 
vs. 1.6 *10-3mm2/s in poorly differentiated tumors 
(p=0.014)). No difference between squamous cell carcinoma 
and adenocarcinoma was found. SUVmax showed no 
differences with regard to tumor type and differentiation 
grade. 
